Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

Share Price is delayed by 15 minutes
Get Live Data
362.50    3.50 (0.97%)
Bid:
362.50
Ask:
363.50
Spread: 1.00 (0.276%)
Market Cap: £1.20b
IHP Live PriceLast checked at - London Stock Exchange

Intraday IntegraFin Holdings Share Chart

Ian Taylor

19 Oct 2022 07:15

RNS Number : 3220D
IntegraFin Holdings plc
19 October 2022
Β 

LEI Number: 213800CYIZKXK9PQYE87

Β 

IntegraFin Holdings plc

Β 

Β 

Β 

19 October 2022

Β 

IntegraFin announces the passing of Co-founder and former Chief Executive Ian Taylor

Β 

Β 

It is with great sadness that IntegraFin announces the death of its Co-founder and former Chief Executive Ian Taylor at the age of 58.

Β 

Ian died peacefully on October 17th after a short illness. He is survived by wife Frances and three children Patrick, Elizabeth and Annie.

Β 

Ian co-founded Transact in 1999 with Michael Howard, became Chief Executive in 2002, and led the business for 19 years as it revolutionised the advisory platform market, and through its IPO in April 2018. He stepped down as Chief Executive in 2020, and retired in February 2021.

Β 

Alex Scott, IHP Chief Executive Officer, said "We are, all, desperately saddened by the news of Ian's passing. Our condolences and thoughts at this time are with Frances, Patrick, Elizabeth, Annie and their wider family.''

Β 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word β€œReach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAEAKEPFLXAFFA
Date   Source Headline
4th Dec 201812:53 pmRNSDirector/PDMR Shareholding
4th Dec 201812:35 pmRNSDisposal of Shares
23rd Nov 20189:54 amRNSHolding(s) in Company
21st Nov 20182:55 pmRNSHolding(s) in Company
7th Nov 20182:33 pmRNSHolding(s) in Company
31st Oct 20183:50 pmRNSHolding(s) in Company
23rd Oct 20187:00 amRNSQ4 Funds Under Direction Update
12th Oct 20184:40 pmRNSHolding(s) in Company
3rd Oct 20185:19 pmRNSHolding(s) in Company
28th Sep 201812:00 pmRNSDirectorate Change
23rd Aug 201812:00 pmRNSHolding(s) in Company
22nd Aug 201812:00 pmRNSDirectorate Change
14th Aug 20187:00 amRNSHolding(s) in Company
31st Jul 20187:00 amRNSDirector Declaration
26th Jul 20182:08 pmRNSCorrection: Q3 Funds Under Direction Update
24th Jul 20187:00 amRNSQ3 Funds Under Direction update
20th Jun 20187:00 amRNSHolding(s) in Company
18th May 20187:00 amRNSInterim Results
14th May 20184:40 pmRNSSecond Price Monitoring Extn
14th May 20184:35 pmRNSPrice Monitoring Extension
25th Apr 20183:31 pmRNSHolding(s) in Company
25th Apr 20183:30 pmRNSHolding(s) in Company
24th Apr 20187:00 amRNSQ2 Funds Under Direction update
5th Apr 20188:19 amRNSHolding(s) in Company
2nd Mar 20187:00 amRNSInitial Admission - Official List
27th Feb 20184:01 pmRNSPublication of a Prospectus
27th Feb 20187:00 amRNSPricing Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.